|
Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer |
|
|
|
Titel: |
Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer |
Auteur: |
Zhao, Chen-Chen Zhan, Meng-Na Liu, Wan-Ting Jiao, Yang Zhang, Yi-Yin Lei, Yu Zhang, Teng-Teng Zhang, Cong-Jun Du, Ying-Ying Gu, Kang-Sheng Wei, Wei |
Verschenen in: |
Cancer letters |
Paginering: |
Jaargang 493 () nr. C pagina's 120-127 |
Jaar: |
2020 |
Inhoud: |
|
Uitgever: |
Elsevier B.V. |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|